FDA: Pfizer vaccine 90.7% effective in kids aged 5-11

Friday, 22. October 2021 14:58

The United States Food and Drug Administration (FDA) revealed on Friday its latest study found Pfizer Inc. and BioNTech SE's vaccine against COVID-19 is 90.7% effective against the disease in children aged between five and 11.

The trials were conducted in 2,268 individuals divided into two groups. Those that received both doses of the jab developed an immunity of 90.7% in comparison to those that got a placebo.

Pfizer asked for the FDA's approval for the use of its treatment in kids earlier this month.

Related Links: BioNTech SEPfizer Inc.
Breaking the News / JR